Page last updated: 2024-10-28

hydralazine and Hypercapnia

hydralazine has been researched along with Hypercapnia in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.

Research Excerpts

ExcerptRelevanceReference
"Hydralazine has been shown to increase minute ventilation (VE) in patients with chronic obstructive pulmonary disease and pulmonary hypertension."7.67Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Corriveau, ML; Dolan, GF; Shepard, JW, 1987)
"Hydralazine has been shown to increase minute ventilation (VE) in patients with chronic obstructive pulmonary disease and pulmonary hypertension."3.67Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension. ( Corriveau, ML; Dolan, GF; Shepard, JW, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corriveau, ML1
Shepard, JW1
Dolan, GF1

Other Studies

1 other study available for hydralazine and Hypercapnia

ArticleYear
Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    The American review of respiratory disease, 1987, Volume: 135, Issue:1

    Topics: Administration, Oral; Cardiac Catheterization; Drug Evaluation; Hemodynamics; Humans; Hydralazine; H

1987